A Study of LY3471851 in Adults With Systemic Lupus Erythematosus (SLE)
Clinical trial NCT04433585 · COMPLETED
Trial details
- NCT number
- NCT04433585
- Sponsor
- Nektar Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-19
- Primary completion
- 2023-01-10
- Enrollment
- 291
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.